Binding interactions of bacterial lipopolysaccharide and the cationic amphiphilic peptides polymyxin B and WLBU2

Colloids and Surfaces B: Biointerfaces

Volumn 120, Issue , 2014, Pages 81-87

  Ryder, Matthew P ^a   Wu, Xiangming ^a   McKelvey, Greg R ^a   McGuire, Joseph ^a   Schilke, Karl F ^a  

^a Oregon State University   (United States)

Author keywords

Cationic amphiphilic peptides; Endotoxin; Interfacial tensiometry; Lipopolysaccharide; Polymyxin B; Sepsis; WLBU2

Indexed keywords

BACTERIA; BINDING ENERGY; BLOOD; DEGRADATION; DYNAMIC LIGHT SCATTERING; MEMBRANES; MIXTURES;

AMPHIPHILIC PEPTIDES; ENDOTOXIN; LIPOPOLYSACCHARIDES; POLYMYXIN B; SEPSIS; TENSIOMETRY; WLBU2;

PEPTIDES;

ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIUM LIPOPOLYSACCHARIDE; POLYMYXIN B; UNCLASSIFIED DRUG; WLBU2 PEPTIDE; LIPOPOLYSACCHARIDE; PROTEIN BINDING; SURFACTANT; WATER;

ADSORPTION KINETICS; AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG BINDING; DRUG STRUCTURE; HEMOPERFUSION; LIGHT SCATTERING; MOLECULAR INTERACTION; PARTICLE SIZE; PRIORITY JOURNAL; STRUCTURE ANALYSIS; ADSORPTION; AIR; AMINO ACID SEQUENCE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; KINETICS; METABOLISM; MOLECULAR GENETICS; MOLECULAR WEIGHT; SURFACE TENSION;

ADSORPTION; AIR; AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; CIRCULAR DICHROISM; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PARTICLE SIZE; POLYMYXIN B; PROTEIN BINDING; SURFACE TENSION; SURFACE-ACTIVE AGENTS; WATER;

EID: 84901757892     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.05.004     Document Type: Article

References (42)

1. Angus D.C., Wax R.S. Epidemiology of sepsis: an update. Crit. Care Med. 2001, 29:S109-S116.
2. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
3. Wood K., Angus D. Pharmacoeconomic implications of new therapies in sepsis. Pharmacoeconomics 2004, 22:895-906.
4. Matsuno N., Ikeda T., Ikeda K., Hama K., Iwamoto H., Uchiyama M., Kozaki K., Narumi Y., Kikuchi K., Degawa H., Nagao T. Changes of cytokines in direct endotoxin adsorption treatment on postoperative multiple organ failure. Ther. Apher. 2001, 5:36-39.
5. Anspach F.B. Endotoxin removal by affinity sorbents. J. Biochem. Biophys. Methods 2001, 49:665-681.
6. Buttenschoen K., Radermacher P., Bracht H. Endotoxin elimination in sepsis: physiology and therapeutic application. Langenbeck's Arch. Surg. 2010, 395:597-605.
7. Davies B., Cohen J. Endotoxin removal devices for the treatment of sepsis and septic shock. Lancet Infect. Dis. 2011, 11:65-71.
8. Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis:Endotoxin adsorption cartridge (Toraymyxin). Theor. Apheresis Dial. 2003, 7:108-114.
9. Vincent J.-L., Laterre P.-F., Cohen J., Burchardi H., Bruining H., Lerma F.A., Wittebole X., De Backer D., Brett S., Marzo D., Nakamura H., John S. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005, 23:400-405.
10. Ikeda T. Hemoadsorption in critical care. Ther. Apher. 2002, 6:189-192.
11. Ueno T., Sugino M., Nemoto H., Shoji H., Kakita A., Watanabe M. Effect over time of endotoxin adsorption therapy in sepsis. Theor. Apheresis Dial. 2005, 9:128-136.
12. Hlady V., Buijs J. Protein adsorption on solid surfaces. Curr. Opin. Biotechnol. 1996, 7:72-77.
13. Neff J.A., Tresco P.A., Caldwell K.D. Surface modification for controlled studies of cell-ligand interactions. Biomaterials 1999, 20:2377-2393.
14. Onaizi S.A., Leong S.S.J. Tethering antimicrobial peptides: current status and potential challenges. Biotechnol. Adv. 2011, 29:67-74.
15. Anspach F.B., Hilbeck O. Removal of endotoxins by affinity sorbents. J. Chromatogr. 1995, 711:81-92.
16. Li J., Nation R.L., Turnidge J.D., Milne R.W., Coulthard K., Rayner C.R., Paterson D.L. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect. Dis. 2006, 6:589-601.
17. Hogardt M., Schmoldt S., Götzfried M., Adler K., Heesemann J. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J. Antimicrob. Chemother. 2004, 54:1057-1061.
18. Hancock R.E.W. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 2001, 1:156-164.
19. Hancock R.E.W., Rozek A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 2002, 206:143-149.
20. Gough M., Hancock R., Kelly N. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 1996, 64:4922-4927.
21. Scott M.G., Yan H., Hancock R.E.W. Biological properties of structurally related a-helical cationic antimicrobial peptides. Infect. Immun. 1999, 67:2005-2009.
22. Cirioni O., Giacometti A., Ghiselli R., Bergnach C., Orlando F., Silvestri C., Mocchegiani F., Licci A., Skerlavaj B., Rocchi M., Saba V., Zanetti M., Scalise G. LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Antimicrob. Agents Chemother. 2006, 50:1672-1679.
23. Deslouches B., Gonzalez I.A., DeAlmeida D., Islam K., Steele C., Montelaro R.C., Mietzner T.A. De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J. Antimicrob. Chemother. 2007, 60:669-672.
24. Deslouches B., Islam K., Craigo J.K., Paranjape S.M., Montelaro R.C., Mietzner T.A. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob. Agents Chemother. 2005, 49:3208-3216.
25. Deslouches B., Phadke S.M., Lazarevic V., Cascio M., Islam K., Montelaro R.C., Mietzner T.A. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 2005, 49:316-322.
26. R.C. Montelaro T.A. Mietzner, Virus derived antimicrobial peptides, U.S. Patent 6,887,847, 2005.
27. I.A. Gonzalez, X.X. Wong, D. De Almeida, R. Yurko, S. Watkins, K. Islam, R.C. Montelaro, A. El-Ghannam, T.A. Mietzner, Peptides as potent antimicrobials tethered to a solid surface: implications for medical devices, Nature Preced. (2008).
28. Skinner M.C., Kiselev A.O., Isaacs C.E., Mietzner T.A., Montelaro R.C., Lampe M.F. Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis. Antimicrob. Agents Chemother. 2010, 54:627-636.
29. Costa F., Carvalho I.F., Montelaro R.C., Gomes P., Martins M.C.L. Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces. Acta Biomater. 2011, 7:1431-1440.
30. McClanahan J.R., Peyyala R., Mahajan R., Montelaro R.C., Novak K.F., Puleo D.A. Bioactivity of WLBU2 peptide antibiotic in combination with bioerodible polymer. Int. J. Antimicrob. Agents 2011, 38:530-533.
31. Pace C.N., Vajdos F., Fee L., Grimsley G., Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 1995, 4:2411-2423.
32. Ryder M.P., McGuire J., Schilke K.F. Cleaning requirements for silica-coated sensors used in optical waveguide lightmode spectroscopy. Surf. Interface Anal. 2013, 45:1805-1809.
33. Popat K.C., Johnson R.W., Desai T.A. Characterization of vapor deposited thin silane films on silicon substrates for biomedical microdevices. Surf. Coat. Technol. 2002, 154:253-261.
34. Dill J.K., Auxier J.A., Schilke K.F., McGuire J. Quantifying nisin adsorption behavior at pendant PEO layers. J. Colloid Interface Sci. 2013, 395:300-305.
35. Lampi M.C., Wu X., Schilke K.F., McGuire J. Structural attributes affecting peptide entrapment in PEO brush layers. Colloids Surf. B. Biointerfaces 2013, 106:79-85.
36. Ramsden J.J. Porosity of pyrolysed sol-gel waveguides. J. Mater. Chem. 1994, 4:1263-1265.
37. Whitmore L., Wallace B.A. Dichroweb, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 2004, 32:W668-W673.
38. Whitmore L., Wallace B.A. Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 2008, 89:392-400.
39. Herráez A. Biomolecules in the computer: Jmol to the rescue. Biochem. Mol. Biol. Educ. 2006, 34:255-261.
40. Maupetit J., Derreumaux P., Tuffery P. Pep-fold: an online resource for de novo peptide structure prediction. Nucleic Acids Res. 2009, 37:W498-W503.
41. Thévenet P., Shen Y., Maupetit J., Guyon F., Derreumaux P., Tufféry P. Pep-fold: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res. 2012, 40:W288-W293.
42. Wu X., Ryder M.P., McGuire J., Schilke K.F. Adsorption, structural alteration and elution of peptides at pendant PEO layers. Colloids Surf. B. Biointerfaces 2013, 112:23-29.